Summit Therapeutics Inc.
- SMMT
- NASDAQ
- Biotechnology
- Infectious Disease Therapeutics
$14.63
Today −4.81%Quote Oct 16, 2026, 08:00 PM UTC
−17.44%over the last month
Max drawdown −18.5%From 1-month high −18.5%3 months +8.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$11.67B
Quote Oct 16
Next earnings
Oct 19
Expected, not confirmed
Analyst target
$29.33
+100.5% from here
Floor
—
Data unavailable
Where the price sits
23 analysts
Analyst range, low to high
$16.00$41.00
- Price $14.63
- Resistance $14.69
- Consensus $29.33
The price is right under resistance. Analysts' average target sits about 100% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SMMTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
265